|
US5939262A
(en)
*
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
|
DE19737442C2
(de)
*
|
1997-08-22 |
1999-06-24 |
Olfert Landt Tib Molbiol Synth |
Proteinumhüllte Polyribonukleinsäuren, ein Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
EP1892299A3
(en)
*
|
1997-09-19 |
2011-07-20 |
Life Technologies Corporation |
Sense mRNA therapy
|
|
JP2002508299A
(ja)
*
|
1997-09-19 |
2002-03-19 |
セクイター， インク． |
センスｍＲＮＡ治療
|
|
US7767422B2
(en)
*
|
1998-09-22 |
2010-08-03 |
Oncomedx, Inc. |
Detection of 5T4 RNA in plasma and serum
|
|
US6777210B1
(en)
*
|
1998-09-24 |
2004-08-17 |
Ambion, Inc. |
Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1
|
|
DE19956568A1
(de)
*
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
KR20000065690A
(ko)
*
|
1999-04-08 |
2000-11-15 |
박종구 |
반응 특이성 및 안정성을 개선시킨 안티센스 올리고 뉴클레오타이드, 안티센스 ｄｎａ 및 그 제조방법
|
|
US7829693B2
(en)
*
|
1999-11-24 |
2010-11-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a target gene
|
|
CA2402452A1
(en)
*
|
2000-03-31 |
2001-10-11 |
Cambridge Antibody Technology Limited |
Improvements to ribosome display
|
|
ATE498020T1
(de)
*
|
2000-08-28 |
2011-02-15 |
Oncomedx Inc |
5t4 rna in plasma und serum als marker für neoplastische erkrankungen
|
|
GB0021303D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Medinnova Sf |
Use
|
|
RU2189396C2
(ru)
*
|
2000-10-27 |
2002-09-20 |
Федеральное государственное учреждение науки и здравоохранения Нижегородский научно-исследовательский институт эпидемиологии и микробиологии им. акад. И.Н.Блохиной |
Способ обнаружения и дифференциации рнк энтеровирусов
|
|
US8546143B2
(en)
|
2001-01-09 |
2013-10-01 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a target gene
|
|
US20020172972A1
(en)
*
|
2001-05-15 |
2002-11-21 |
President And Fellows Of Harvard College |
Use of a selectively inactivatable enzyme to digest contaminating nucleic acid
|
|
JP2005514012A
(ja)
*
|
2001-12-06 |
2005-05-19 |
ザ アーロン ダイアモンド エイズ リサーチ センター |
キメラバクテリオファージ標準を使用する高感度ゲノムアッセイ
|
|
EP2290098A1
(en)
|
2002-01-28 |
2011-03-02 |
Ambion, Inc. |
Preparing crude biological extracts using protease, suitable for preparing cDNA
|
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
|
CA2474910A1
(en)
|
2002-02-01 |
2003-08-07 |
Sequitur, Inc. |
Oligonucleotide compositions with enhanced efficiency
|
|
JP2006507800A
(ja)
*
|
2002-06-07 |
2006-03-09 |
ラージ・スケール・バイオロジー・コーポレイション |
可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム
|
|
US7482116B2
(en)
|
2002-06-07 |
2009-01-27 |
Dna Genotek Inc. |
Compositions and methods for obtaining nucleic acids from sputum
|
|
WO2004085611A2
(en)
*
|
2003-03-21 |
2004-10-07 |
The Research Foundation Of State University Of New York |
Model for mutually exclusive domain folding molecular switch
|
|
GB2422196B
(en)
*
|
2003-05-20 |
2008-05-07 |
Investigen Inc |
System for detecting polynucleotides
|
|
CN100577680C
(zh)
|
2003-07-03 |
2010-01-06 |
宾夕法尼亚大学理事会 |
对Syk激酶表达的抑制
|
|
EP1694692B1
(en)
*
|
2003-12-16 |
2010-04-28 |
QIAGEN North American Holdings, Inc. |
Formulations and methods for denaturing proteins
|
|
CA2561741C
(en)
|
2004-04-05 |
2016-09-27 |
Alnylam Pharmaceuticals, Inc. |
Processes and reagents for oligonucleotide synthesis and purification
|
|
US7626014B2
(en)
|
2004-04-27 |
2009-12-01 |
Alnylam Pharmaceuticals |
Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
|
|
AU2005323437B2
(en)
*
|
2004-04-30 |
2011-10-06 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a C5-modified pyrimidine
|
|
CA2572151A1
(en)
*
|
2004-06-30 |
2006-08-24 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a non-phosphate backbone linkage
|
|
WO2006093526A2
(en)
|
2004-07-21 |
2006-09-08 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a modified or non-natural nucleobase
|
|
US7632932B2
(en)
|
2004-08-04 |
2009-12-15 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
|
|
US7309589B2
(en)
|
2004-08-20 |
2007-12-18 |
Vironix Llc |
Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
|
|
EP2309269B1
(en)
|
2004-09-08 |
2016-10-26 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Compositions and methods for the detection of HIV-1/HIV-2 infection.
|
|
WO2006045591A2
(en)
*
|
2004-10-25 |
2006-05-04 |
Devgen N.V. |
Method and constructs for delivering double stranded rna to pest organisms
|
|
KR20070097430A
(ko)
|
2004-11-05 |
2007-10-04 |
퀴아젠 노쓰 아메리칸 홀딩즈, 인크. |
안정화 시약으로부터 핵산을 정제하기 위한 조성물 및 방법
|
|
JP2009501531A
(ja)
*
|
2005-07-15 |
2009-01-22 |
アプレラ コーポレイション |
Ｒｎａプロファイリングのための方法
|
|
WO2007100711A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Investigen, Inc. |
Methods and compositions for detecting polynucleotides
|
|
JP2010505396A
(ja)
|
2006-10-06 |
2010-02-25 |
ディーエヌエー ジェノテック インク |
リボ核酸を抽出するための安定化組成物および方法
|
|
WO2008051817A1
(en)
*
|
2006-10-20 |
2008-05-02 |
Novartis Ag |
Compositions and method for monitoring bcr-abl expression
|
|
US20080096193A1
(en)
*
|
2006-10-24 |
2008-04-24 |
Charles Robert Bupp |
Methods and compositions for detecting polynucleotides
|
|
CN101173252B
(zh)
*
|
2006-10-31 |
2011-09-21 |
杭州市疾病预防控制中心 |
披甲rna及其制备方法
|
|
WO2008103702A2
(en)
*
|
2007-02-23 |
2008-08-28 |
Investigen, Inc. |
Methods and compositions for rapid light-activated isolation and detection of analytes
|
|
US7964350B1
(en)
|
2007-05-18 |
2011-06-21 |
Applied Biosystems, Llc |
Sample preparation for in situ nucleic acid analysis
|
|
EP2268801A4
(en)
*
|
2008-03-14 |
2011-12-28 |
Us Gov Health & Human Serv |
COMPOSITIONS AND METHODS RELATED TO A HUMAN BOCAVIRUS
|
|
US8324149B2
(en)
*
|
2008-11-18 |
2012-12-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Encapsidation of heterologous entities into virus-like particles
|
|
US20100129902A1
(en)
*
|
2008-11-24 |
2010-05-27 |
Erhard Ralf Schoenbrunner |
Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
|
|
US8211637B2
(en)
*
|
2008-12-19 |
2012-07-03 |
Life Technologies Corporation |
Proteinase K inhibitors, methods and compositions therefor
|
|
CN107604097A
(zh)
|
2010-07-29 |
2018-01-19 |
霍夫曼-拉罗奇有限公司 |
用于多种参数的对照核酸
|
|
CN107190056A
(zh)
*
|
2010-07-29 |
2017-09-22 |
霍夫曼-拉罗奇有限公司 |
微生物核酸的定性和定量检测
|
|
JP6169489B2
(ja)
|
2010-07-29 |
2017-07-26 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
一般的な試料調製
|
|
US8877464B2
(en)
|
2010-07-29 |
2014-11-04 |
Roche Molecular Systems, Inc. |
Qualitative and quantitative detection of microbial nucleic acids
|
|
JP6121591B2
(ja)
*
|
2010-07-29 |
2017-04-26 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
微生物核酸の定性的および定量的検出
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2426222A1
(en)
|
2010-09-07 |
2012-03-07 |
F. Hoffmann-La Roche AG |
Generic buffer for amplification
|
|
CA2821992A1
(en)
|
2010-10-01 |
2012-04-05 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2465945A1
(en)
|
2010-12-17 |
2012-06-20 |
F. Hoffmann-La Roche AG |
Generic matrix for control nucleic acids
|
|
DE12722942T1
(de)
|
2011-03-31 |
2021-09-30 |
Modernatx, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
|
BR112013032629A2
(pt)
|
2011-06-19 |
2017-08-01 |
Abogen Inc |
dispositivos, soluções e métodos para coletamento de amostra
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
HRP20220250T1
(hr)
|
2011-10-03 |
2022-04-29 |
Modernatx, Inc. |
Modificirani nukleozidi, nukleotidi i nukleinske kiseline, te njihove uporabe
|
|
SI2791160T1
(sl)
|
2011-12-16 |
2022-07-29 |
Modernatx, Inc. |
Sestave modificirane MRNA
|
|
US10066213B2
(en)
|
2012-03-13 |
2018-09-04 |
Emd Millipore Corporation |
Use of centrifugation-aided infection to increase virus titer
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
AU2013243952A1
(en)
|
2012-04-02 |
2014-10-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
SMT202200337T1
(it)
|
2012-11-26 |
2022-09-14 |
Modernatx Inc |
Rna modificato al livello del terminale
|
|
DK2968424T3
(da)
|
2013-03-13 |
2020-03-30 |
Geneweave Biosciences Inc |
Ikke-replikative transduktionspartikler og transduktionspartikelbaserede reportersystemer
|
|
US9481903B2
(en)
|
2013-03-13 |
2016-11-01 |
Roche Molecular Systems, Inc. |
Systems and methods for detection of cells using engineered transduction particles
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
US10323076B2
(en)
|
2013-10-03 |
2019-06-18 |
Modernatx, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
US9540675B2
(en)
|
2013-10-29 |
2017-01-10 |
GeneWeave Biosciences, Inc. |
Reagent cartridge and methods for detection of cells
|
|
US20160355896A1
(en)
*
|
2014-02-10 |
2016-12-08 |
Amptec Gmbh |
Incoated rna
|
|
SG10201912038TA
(en)
|
2014-04-23 |
2020-02-27 |
Modernatx Inc |
Nucleic acid vaccines
|
|
GB201412316D0
(en)
*
|
2014-07-10 |
2014-08-27 |
Momentum Bioscience Ltd |
Detecting the absence of micro-organisms
|
|
US11015217B2
(en)
|
2015-05-29 |
2021-05-25 |
Roche Molecular Systems, Inc. |
Method of inactivating microbes by citraconic anhydride
|
|
US10351893B2
(en)
|
2015-10-05 |
2019-07-16 |
GeneWeave Biosciences, Inc. |
Reagent cartridge for detection of cells
|
|
EP3368694A1
(en)
|
2015-10-28 |
2018-09-05 |
Life Science Inkubator GmbH |
Use of vlp for the detection of nucleic acids
|
|
US10689689B2
(en)
*
|
2015-12-28 |
2020-06-23 |
Roche Molecular Systems, Inc. |
Generic method for the stabilization of specific RNA
|
|
US20170356025A1
(en)
|
2016-06-14 |
2017-12-14 |
Roche Molecular Systems, Inc. |
Internal control probes for improving pcr assay performance
|
|
EP3299471B1
(en)
|
2016-09-23 |
2019-10-23 |
Roche Diagniostics GmbH |
Methods for determining the amount of a nucleic acid of interest in an unprocessed sample
|
|
US10422012B2
(en)
|
2016-10-10 |
2019-09-24 |
Roche Molecular Systems, Inc. |
Devices comprising bacteriophage PHI6 internal control compositions
|
|
WO2019070854A1
(en)
|
2017-10-03 |
2019-04-11 |
Abbott Molecular Inc. |
ASSAY FOR DETECTION OF HEPATITIS C VIRUS (HCV)
|
|
EP3628059B1
(en)
|
2017-10-03 |
2023-04-12 |
Abbott Molecular Inc. |
Assay for detecting human immunodeficiency virus (hiv)
|
|
CA3088866A1
(en)
|
2018-01-09 |
2019-07-18 |
Abbott Molecular Inc. |
Assay for detecting chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis, and mycoplasma genitalium
|
|
CN115896243A
(zh)
*
|
2022-11-25 |
2023-04-04 |
上海厦维医学检验实验室有限公司 |
基于混合酶体系的超灵敏反转录方法及其应用
|